CME Presentations

Clinical Trial Diversity in Breast Cancer



  • Melody Taylor, MSN, RN, CCM

    Melody Taylor, MSN, RN, CCM

    Melody Taylor, MSN, RN, CCM


    Melody Taylor, MSN is a registered nurse at Orlando Health with over 20 years of experience in providing high-quality patient care. She has worked in various areas of nursing with nursing leadership being the focus. Outside of the clinical setting, she actively engages in community initiatives, aiming to reduce health care disparities in vulnerable communities in Central Florida, and is the president of Black Nurses Rock Orlando and the vice president of the Black Nurses Rock Foundation. Melody is also a member of the Florida Nurses Association, the American Nurses Association, and the American Academy of Ambulatory Care Nurses. She is dedicated to continuous learning and professional development, staying abreast of the latest advancements in nursing to deliver high standards of care.
  • Monique Gary, DO, MSc, FACS

    Monique Gary, DO, MSc, FACS

    Monique Gary, DO, MSc, FACS

    Medical Director

    Monique Gary, DO, MSc, FACS, is a board certified, fellowship-trained breast cancer surgeon and Medical Director of the Grand View Health Cancer Program (Penn Cancer Network) in Sellersville, PA, where she also serves as director of the Breast Program. Dr. Gary holds faculty appointments in surgery and serves as the professor for Race & Health Equity at Dartmouth Geisel School of Medicine. She has been published in multimedia and peer reviewed journals, and she serves as a medical advisor/contributor for national breast cancer advocacy organizations like Living Beyond Breast Cancer, Touch, and Tigerlily Foundation. Dr. Gary’s practice specializes in oncoplastic and hidden scar minimally invasive breast cancer surgery as well as genetic risk assessment, cancer nutrition and prevention.

CME Information

Global LogoPQH Logo

Nurses Light the Path: Empowering Patients to Improve Breast Cancer Screening and Clinical Trial Representation

Jointly provided by Partners for Advancing Clinical Education (PACE) and PlatformQ Health Education, LLC, in collaboration with Black Nurses Rock


This activity is supported by an independent medical education grant from Daiichi Sankyo, Inc.


This activity was released on March 8, 2024 and is valid until March 8, 2025. Requests for credit must be made no later than March 8, 2025.


The primary target audience for this activity is Oncology Nursing Professionals (APRN, NP, RN).


For women with breast cancer and those at risk, disparities in screening and clinical-trial enrollment exist, particularly among racial and ethnic minority populations. Awareness of these disparities can ensure timely screening practices and help address patient fears and concerns regarding clinical trials that inhibit diverse representation in research. Younger women should be educated on their higher risk for aggressive breast cancer subtypes and empowered to get regular screenings that can aid early detection.

Join an expert panel as they discuss how to reduce disparities and increase equity in clinical trial enrollment. Panelists will also highlight the importance of regular screening for breast cancer and share strategies to provide patients with support, education, and resources to make informed decisions on these topics.


After completing this activity, the participant should be better able to:
  • Demonstrate appropriate screening practices for women at risk of breast cancer
  • Describe strategies to address disparities in clinical trial enrollment
  • Provide patients with support, education, and resources to make informed decisions regarding screening and clinical trial enrollment


JointlyAccreditedProvider Logo In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and PlatformQ Health Education, LLC. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1 contact hour.


This activity should take approximately 1 hour to complete.


In order to receive credit for this activity, the participant must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive nursing contact hours participants must receive a score of 75% on the post-test.


Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.


There is no fee for this educational activity.


PACE requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to PACE policies. Others involved in the planning of this activity have no relevant financial relationships.

Faculty Conflicts of Interest
Monique Gary, DO, FACS, FSSO
Breast Surgical Oncologist
Medical Director, Cancer Program
Grand View Health/Penn Cancer Network
Associate Professor of Surgery
Philadelphia College of Osteopathic Medicine
Dr. Monique Gary, faculty for this educational activity, has the following relevant financial relationships:
• Consultant, Advisor, Speaker: Novartis, Gilead
Melody Taylor, DNP, RN, CCM
Black Nurses Rock

Melody Taylor, faculty for this educational activity, has no relevant financial relationships.


This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.


Accreditation Support:

For additional information about the accreditation of this activity, please visit

Technical Support:

For any technical issues or issues with your CME Certificate, please contact ImmunologyLive at 877-394-1306 or at